头皮糜烂性脓疱性皮病研究进展  

Erosive pustular dermatosis of the scalp

作　　者：陈启韬 李煜乾 邵光辉 朱晶 朱麒麟 李中明[1] 杜旭峰[1] 范卫新[2] Chen Qitao;Li Yuqian;Shao Guanghui;Zhu Jing;Zhu Qilin;Li Zhongming;Du Xufeng;Fan Weixin(Wuxi People′s Hospital Affiliated to Nanjing Medical University,Wuxi 214000,Jiangsu,China;Department of Dermatology and Venereology,the First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China)

机构地区：[1]南京医科大学附属无锡市人民医院皮肤科,无锡214000 [2]南京医科大学第一附属医院皮肤性病科,南京210029

出　　处：《中华皮肤科杂志》2025年第3期272-275,共4页Chinese Journal of Dermatology

基　　金：无锡市太湖人才计划高层次人才培养项目(HB2020011);无锡市卫生健康委科研项目计划(M202025)。

摘　　要：头皮糜烂性脓疱性皮病是一种较罕见的浅表皮肤炎症性疾病,发病机制尚不明确。该病临床表现与感染性炎症和恶性肿瘤有相似之处,诊断高度依赖非特异性的病理改变,因此诊断有一定难度。治疗以糖皮质激素外用为主,但个体治疗差异大,难治患者需要采取其他治疗手段。本病需长期局部外用糖皮质激素,药物不良反应较多。本文就近年头皮糜烂性脓疱性皮病的研究进展进行综述,以提高临床医生对本病的认识。Erosive pustular dermatosis of the scalp(EPDS)is a rare superficial skin inflammatory disease that occurs on the scalp,and its pathogenesis is still unclear.Its clinical manifestations are similar to those of infectious inflammation and malignant tumors,and its diagnosis is highly dependent on non-specific pathological changes,so the diagnosis is relatively difficult.Clinically,topical glucocorticoids are the main treatment method,but treatment outcomes vary greatly among individuals,and patients with refractory EPDS need other treatment methods.EPDS generally requires long-term topical glucocorticoids,and adverse drug reactions are common.This review summarizes research progress in EPDS in recent years,in order to improve clinicians′understanding of this disease.

关 键 词：头皮皮肤病 病理过程 诊断 鉴别 治疗 头皮糜烂性脓疱性皮病 病因 发病机制 

分 类 号：R73[医药卫生—肿瘤]